1.科研項(xiàng)目 (1) 國(guó)家自然科學(xué)基金青年科學(xué)基金項(xiàng)目,82101579,, LncRNAPPIHP1-201通過(guò)NDUFAB1介導(dǎo)線粒體損傷在早發(fā)精神分裂癥中的作用機(jī)制研究,,30萬(wàn)元,,主持 (2) 山西省教育廳,山西省籌資金資助回國(guó)留學(xué)人員科研項(xiàng)目,,2021-167,,線粒體DNA甲基化在雙相抑郁患者能量代謝異常中的作用,5.0萬(wàn)元,,主持 2.學(xué)術(shù)論文 (1) Comparing the metabolic pathways of different clinical phases of bipolar disorder through metabolomics studies. Frontiers in Psychiatry. 2024 Jan 8;14:1319870.(通訊作者) (2) Exploring hub genes and crucial pathways linked to oxidative stress in bipolar disorder depressive episodes through bioinformatics analysis, Frontiers in Psychiatry, 2024, 15: 132352.(通訊作者) (3) Metabolomic biomarkers related to non-suicidal self-injury in patients with bipolar disorder, BMC Psychiatry, 2022, 22(1): 491-491.(通訊作者) (4) Chaigui granule exerts anti-depressant effects by regulation the synthsis of Estradiol and the downstream CYP19A1-E2-ERKs signaling pathway in CUMS-induced depressed rats. Frontiers in Pharmacology. 2022 October 24,;13:1005438.(通訊作者) 3. 學(xué)術(shù)榮譽(yù):山西省“三晉英才”支持計(jì)劃青年優(yōu)秀人才 4. 科技獎(jiǎng)勵(lì):任燕(5/6),基于遺傳導(dǎo)航技術(shù)的重性精神疾病診療評(píng)估體系研究,,山西省科技廳,,山西省科技進(jìn)步獎(jiǎng)自然科學(xué)獎(jiǎng),一等獎(jiǎng),,2021.7,,2020-Z-1-004 5. 發(fā)明專利:無(wú) 6. 學(xué)術(shù)任職:中華醫(yī)學(xué)會(huì)精神醫(yī)學(xué)分會(huì)精神分裂癥研究協(xié)作組委員;中國(guó)神經(jīng)科學(xué)學(xué)會(huì)精神病學(xué)基礎(chǔ)與臨床分會(huì)青年委員,;山西省醫(yī)學(xué)會(huì)行為醫(yī)學(xué)專業(yè)委員會(huì)副主任委員,;山西省醫(yī)學(xué)會(huì)精神病學(xué)會(huì)常務(wù)委員 |